Trial Profile
A Phase II Open Label Multiple-Dose Study of the Safety and Pharmacokinetics of TDT 067 Under Conditions of Maximal Use in Subjects With Distal Subungual Onychomycosis of the Toenails
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 May 2014
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary) ; Terbinafine (Primary)
- Indications Onychomycosis
- Focus Pharmacokinetics
- Sponsors Celtic Pharma
- 23 May 2014 New trial record